With initial intent to examine the impact of tumor antigen presentation on facets of the TME, we used CRISPR to knock out (KO) the gene encoding β2m in the CT2A-TRP2 line, generating the CT2A-TRP2-β2mKO line (Fig. 1b). This evidence concerns the gene B2M and neoplasm.